Pharma Journalist - Page 15 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Catalent, S.Biomedics Partner on Parkinson’s Cell Therapy

Johnson & Johnson Invests $1 Billion in Pennsylvania

Unnatural Products, Novartis Partner on Macrocyclic Therapies

Scribe, Lilly Advance CRISPR Therapies With Milestone

Teijin, Aska Partner on Gynecology Drug Discovery

The Toxicology Meeting That’s Different – Made for Biotech and Pharma Leaders

Immunic Raises $400M to Advance MS Drug Plans

FDA Rejects Bitopertin Accelerated Approval for Rare Disorder

PTC Withdraws Translarna FDA Application After Feedback

ArkBio Wins U.S. Clearance for IPF Drug Trial